Clinical trials

  • JNJ-88545223 for Active psoriatic arthritis|Psoriatic arthritis
  • FULVESTRANT for HR-positive, HER2-negative metastatic breast cancer | Metastatic breast cancer
  • ONFEKAFUSP ALFA for Basal cell carcinoma | Locally advanced basal cell carcinoma
  • BIFIKAFUSP ALFA for Locally advanced basal cell carcinoma
  • CENEGERMIN for Persistent corneal epithelial defect
  • BG-75098 for Advanced solid tumors|Ovarian cancer|Triple negative breast cancer|Hormone receptor positive HER2 negative breast cancer|Endometrial cancer|Gastric cancer|Prostate cancer|Bladder cancer|Small cell lung cancer|Gastroesophageal junction adenocarcinoma
  • NINTEDANIB for Idiopathic pulmonary fibrosis
  • Clinical trial in Advanced solid tumors | Advanced B-cell lymphomas
  • Clinical trial in Psoriasis
  • PRALSETINIB for Advanced or metastatic solid tumors
  • 2-Methoxyestradiol
  • fenfluramine hydrochloride for Rett syndrome